Compounds > phosphine
Page last updated: 2024-08-22

phosphine and Experimental Neoplasms

phosphine has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, L; Li, C; Liu, J; Liu, Y; Song, S; Wang, Y; Yang, Y; Zhang, H; Zhang, S; Zhang, T; Zhao, Y; Zhen, W; Zhu, J1
Anjum, R; Cai, L; Clackson, T; Dalgarno, D; Dodd, R; Dwight, TA; Huang, WS; Jang, HG; Keats, J; Kohlmann, A; Li, F; Liu, S; Lu, X; Mohemmad, QK; Moran, LE; Narasimhan, NI; Ning, Y; Parillon, L; Qi, J; Rivera, VM; Romero, J; Shakespeare, WC; Thomas, M; Toms, A; Wang, F; Wang, Y; Wardwell, SD; Xu, Q; Xu, R; Xu, Y; Zhang, S; Zhou, T; Zhu, X; Zou, D1
CHOU, CH; HSU, B; LIANG, HC1

Other Studies

3 other study(ies) available for phosphine and Experimental Neoplasms

ArticleYear
One-Dimensional Fe
    Angewandte Chemie (International ed. in English), 2019, 02-18, Volume: 58, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Ferrous Compounds; HeLa Cells; Humans; Hydrogen Peroxide; Infrared Rays; Iron; Mice; Neoplasms, Experimental; Phosphines; Photoacoustic Techniques; Theranostic Nanomedicine; Ultrasonography; Uterine Cervical Neoplasms

2019
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.
    Journal of medicinal chemistry, 2016, 05-26, Volume: 59, Issue:10

    Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Molecular Conformation; Neoplasms, Experimental; Organophosphorus Compounds; Phosphines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship

2016
[THE ANTITUMOUR ACTION AND TOXICITY OF BIS-(1-AZIRIDINYL)-(BIS-(2-CHLOROETHYL)-AMINO)-PHOSPHINE OXIDE (AT-222) IN ANIMALS].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1964, Volume: 11

    Topics: Dogs; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Oxides; Phosphines; Rats; Research; Toxicology

1964